scholarly journals The effect of dietary counselling on food intakes in pregnant women at risk for gestational diabetes: a secondary analysis of a randomised controlled trial RADIEL

2015 ◽  
Vol 70 (8) ◽  
pp. 912-917 ◽  
Author(s):  
A Valkama ◽  
S Koivusalo ◽  
J Lindström ◽  
J Meinilä ◽  
H Kautiainen ◽  
...  
Nutrients ◽  
2020 ◽  
Vol 12 (6) ◽  
pp. 1793
Author(s):  
Laura C Kusinski ◽  
Helen R Murphy ◽  
Emanuella De Lucia Rolfe ◽  
Kirsten L. Rennie ◽  
Linda M. Oude Griep ◽  
...  

The authors would like to correct an error in a recent published paper [...]


2019 ◽  
Vol 9 ◽  
pp. 11-18 ◽  
Author(s):  
Catalin S. Buhimschi ◽  
Kathleen A. Jablonski ◽  
Dwight J. Rouse ◽  
Michael W. Varner ◽  
Uma M. Reddy ◽  
...  

BMJ Open ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. e045503
Author(s):  
Tingting Xu ◽  
Xiaozhen Lai ◽  
Kun He ◽  
Liangkun Ma ◽  
Hai Fang

IntroductionGestational diabetes mellitus (GDM) has become an increasing health problem among pregnant women in western rural China. Insufficient compliance and motivation due to economic factors is one of the major contributors to the currently low GDM screening and management rate. A subsidy program offering GDM screening and lifestyle management might be an effective way to increase pregnant women’s awareness of GDM, and further improve maternal and neonatal health in western rural China. This study had two primary purposes: (1) to examine whether the subsidy program would increase the screening and management rates of GDM and reduce adverse complications for mothers and new-born babies and (2) to evaluate whether the subsidy program is cost-effective from a societal perspective.Methods and analysisThis randomised controlled trial will include 3000 pregnant women (at 24–28 weeks of pregnancy) who will be followed up at six hospitals in the provinces of Yunnan, Sichuan and Shaanxi in China. Pregnant women without overt diabetes, with a singleton pregnancy, with telephone access and with written informed consent will be invited. The intervention group will receive subsidies and standard care, and the control group will only receive usual antenatal care. The randomisation sequence will be stratified by study sites with balanced blocks of six patients. Data will be collected using self-report questionnaires and hospital records. Data will be analysed according to the intention-to-treat principle. The primary outcomes are the maternal and neonatal complications. Secondary outcomes are the mother’s cognition scores, screening rate, number of re-examinations, weight gain during pregnancy, changes in diet and exercise, and quality of life. Group comparisons will be conducted using χ2 test for categorical variables, and t-test or the Mann-Whitney-Wilcoxon test for continuous variables where applicable. Multiple logistic regression will also be performed for the primary outcomes.Ethics and disseminationThis study was approved by the Ethics Review Committee of Peking University Health Science Center. Findings will be disseminated through publication in peer-reviewed journals, seminars and national and international conferences.Trial registration numberChiCTR1800017488.


2021 ◽  
Author(s):  
Ola Quotah ◽  
Glen Nishku ◽  
Jessamine Hunt ◽  
Paul T Seed ◽  
Carolyn Gill ◽  
...  

Abstract BackgroundObesity in pregnancy increases the risk of gestational diabetes mellitus (GDM) and associated adverse outcomes. Despite metabolic differences, all pregnant women with obesity are considered to have the same risk of developing GDM. Improved risk stratification is required to enable targeted intervention in women with obesity who would benefit the most. The aim of this study is to identify pregnant women with obesity at higher risk of developing GDM and in a pilot randomised controlled trial (RCT), show efficacy of a lifestyle intervention and/or metformin to improve glycaemic control.MethodsWomen aged 18 years or older with a singleton pregnancy and body mass index (BMI) ≥30kg/m2 will be recruited from one maternity unit in London, UK. Risk of GDM will be assessed using a multivariable GDM prediction model combining maternal age, mid-arm circumference, systolic blood pressure, serum triglycerides and whole blood HbA1c. Women identified at higher risk of developing GDM will be randomly allocated to one of two intervention groups (lifestyle advice with or without metformin) or standard antenatal care. Primary outcome; reduction in mean glucose/24hr of 0.5mmol/l as assessed by continuous glucose monitoring. A sample of 60 high risk women is required.DiscussionEarly risk stratification of GDM in pregnant women with obesity and targeted intervention using lifestyle advice with or without metformin could improve glucose tolerance compared to standard antenatal care. If successful, an adequately powered RCT will be performed to investigate whether this strategy is effective in preventing GDM in women with obesity. Ethics and trial registrationThis study has been approved by the NHS Research Ethics Committee (UK IRAS integrated research application system; reference 18/LO/1500). EudraCT Number 2018-000003-16.


Sign in / Sign up

Export Citation Format

Share Document